RxDoctor Payments DataLook up a doctor →

Larry McKenzie, DO

Interventional Pain Medicine · Broken Arrow, OKNPI 1003875212

Payments from drug & device makers

$4,395in general payments, 2019–2025

Across 232 payments — averaging $18.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$532
  • Collegium Pharmaceutical, Inc.$524
  • Averitas Pharma Inc.$380
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$369
  • AstraZeneca$253
  • AbbVie$190
  • plus $2K from 40 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic7$532
Collegium Pharmaceutical, Inc.28$524
Averitas Pharma Inc.17$380
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC24$369
AstraZeneca16$253
AbbVie(2 entities)9$190
Merck14$188
Novartis9$169
GRT US Holding, Inc.11$168
Scilex Pharmaceuticals Inc.9$152
Bayer8$146
Seagen Inc.7$102
Johnson & Johnson(2 entities)5$90
Lilly USA, LLC5$89
Bristol Myers Squibb5$82
Genentech USA, Inc.4$75
Amgen5$67
Takeda Pharmaceuticals U.S.A., Inc.3$61
Baudax Bio Inc.3$49
Puma Biotechnology, Inc.3$47
Teva Pharmaceuticals USA, Inc.3$44
Eisai Inc.3$44
Arbor Pharmaceuticals, Inc.3$43
Sanofi2$36
Lundbeck LLC2$35
Array Biopharma Inc2$33
Saluda Medical Americas, Inc.1$33
Astellas Pharma US Inc2$33
Clovis Oncology, Inc.2$31
Pharmacyclics LLC, An Abbvie Company2$30
Kowa Pharmaceuticals America, Inc.2$27
Epizyme, Inc.2$26
Ipsen Biopharmaceuticals, Inc1$25
E.r. Squibb & Sons, L.L.C.1$22
Tesaro, Inc.1$22
Acceleron Pharma, Inc.1$20
Abbott1$18
Biohaven Pharmaceutical Holding Company Ltd.1$18
Si-bone, Inc.1$18
Convatec Inc.1$17
Kyowa Kirin, Inc.1$17
Coherus Oncology, Inc.1$15
Orexo US, Inc.1$15
Karyopharm Therapeutics Inc.1$15
Vertex1$14
Amneal Pharmaceuticals LLC1$12

How this compares

$4,395 in reported general payments places this provider in the 45th percentile of 27 interventional pain medicine providers in Oklahoma.

See all interventional pain medicine providers in Oklahoma →

Medicare billing

Part B allowed, 2024
$776,122
Medicare patients
959
Services billed
16,707

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Broken Arrow

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →